The higher FSH levels group had low muscle mass than that of the higher FSH levels group among nonsarcopenia participants, however, no difference had been found in muscle mass between the higher and the lower FSH levels group among sarcopenia participants (P = 0.308). The gene discussed is BRD2; the disease is sarcopenia.